MiR-20a down-regulation was described in human HCC, where Mcl-1 (myeloid cell leukemia sequence 1), an anti-apoptotic member of Bcl-2 family, was identified as miR-20a target [49]. The gene discussed is BCL2; the disease is hepatocellular carcinoma.